Showing results (231-240 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|September 30, 2024
Current and future applications of local field potential-guided programming for Parkinson's disease with the Percept™ rechargeable neurostimulatorWeerawat Saengphatrachai, Joohi Jimenez-ShahedNeurodegenerative Disease Management|October 23, 2024
Benefits of self-paced concurrent training on lung function, cardiopulmonary fitness and fatigue perception in patients with multiple sclerosisSonda Jallouli, Rami Maaloul, Sameh Ghroubi, et al.Neurodegenerative Disease Management|August 19, 2024
Walking performance differs between people with multiple sclerosis who perform distinct types of exerciseKristin A Johnson, Victoria M Bandera, Manfred Diehl, et al.Neurodegenerative Disease Management|April 30, 2025
Characteristics of responders to interventions for Parkinson disease: a scoping systematic reviewSidney T Baudendistel, Gammon M EarhartNeurodegenerative Disease Management|April 11, 2025
Effect of neuromodulation on neurogenic bladder in women with multiple sclerosis: a pilot randomized controlled trialPınar Atak Çakir, Vahit Güzelburç, Erkingül Birday, et al.Neurodegenerative Disease Management|December 25, 2025
Amantadine for multiple sclerosis-related fatigue: a systematic review and meta-analysis of randomized controlled trialsMurilo Marmori Cruccioli, Pedro Henrique Teixeira Carneiro, Jorge Ferreira Jasmineiro Pitanga, et al.Neurodegenerative Disease Management|December 25, 2025
Neuropathology of Friedreich ataxia and its links to metabolic pathwaysElizabeth Mercado-Ayón, Michael P Lazaropoulos, Yesica Mercado-Ayón, et al.Neurodegenerative Disease Management|December 30, 2025
Multiple sclerosis expert patient program in Central America: changes in quality of life and lifestyle habitsEmilia Arrighi, Carlos Navas, Natalia Vázquez, et al.Neurodegenerative Disease Management|April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumabCarrie M Hersh, Menglan Pang, Deborah M Miller, et al.Neurodegenerative Disease Management|October 7, 2014
Should we disclose amyloid imaging results to cognitively normal individuals?Joshua D Grill, David K Johnson, Jeffrey M BurnsPageof 55